Skip to main content

Journal of Thrombosis and Thrombolysis

Ausgabe 4/2020

Inhalt (34 Artikel)

Inflammatory markers in thrombosis associated with primary antiphospholipid syndrome

Fernanda T. Arantes, Bruna M. Mazetto, Sabrina S. Saraiva, Laís Q. Tobaldini, Ana Paula R. dos Santos, Joyce Annichino-Bizzacchi, Fernanda A. Orsi

Zur Zeit gratis COVID-19

In vivo demonstration of microvascular thrombosis in severe COVID-19

Douglas Alexandre do Espírito Santo, Anna Cristina Bertoldi Lemos, Carlos Henrique Miranda

Zur Zeit gratis COVID-19

How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report

Ezio Zanon, Samantha Pasca, Elena Campello, Luca Spiezia, Roberto Vettor, Paolo Simioni

Zur Zeit gratis COVID-19

Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic

Benjamin Marchandot, Antonin Trimaille, Anais Curtiaud, Kensuke Matsushita, Laurence Jesel, Olivier Morel

Zur Zeit gratis COVID-19

Concerns for management of STEMI patients in the COVID-19 era: a paradox phenomenon

Panayotis K. Vlachakis, Anastasios Tentolouris, Ioannis Kanakakis

Zur Zeit gratis COVID-19

Long lasting hypercoagulability after subclinical COVID-19

Paolo Ferroli, Chiara Villa, Andrea Ciuffi, Guido Gubertini, Morgan Broggi

Open Access COVID-19

Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19

Yang Liu, Weibo Gao, Wei Guo, Yang Guo, Maojing Shi, Guiying Dong, Qinggang Ge, Jihong Zhu, Jin Lu

Zur Zeit gratis COVID-19 Letter to the Editor

Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis

Chiara Kessler, Hans Stricker, Daniela Demundo, Luigia Elzi, Rita Monotti, Giorgia Bianchi, Michael Llamas, Luca Spinedi, Davide Rossi, Alessandro Felice Chiesa, Alberto Pagnamenta, Marco Conti, Gabriele Casso, Elisa Stoira, Elisa Valenti, Giuseppe Colucci, Georg Stussi, Bernhard Gerber, Marco Previsdomini

Experience of a 40-day (6 week) LMWH treatment for isolated distal deep vein thrombosis

Konstantinos Asonitis, Ekatherina Charvalos, Catherine Lambert, Cedric Hermans

A stricter control of low-density lipoprotein is necessary for thrombosis reduction in “lower thrombosis risk” patients with atrial fibrillation: a multicenter retrospective cohort study

Weizhuo Liu, Nanqing Xiong, Kun Xie, Bangwei Wu, Zhiyong Qi, Peng Zhou, Wen Gao, Liwen Bao, Xiufang Gao, Zhaohui Qiu, Hui Gong, Guibin He, Bin Cao, Haiming Shi, Xinping Luo, Jian Li

Residual platelet reactivity, thrombus burden and myocardial reperfusion in patients treated by PCI after successful pre-hospital fibrinolysis compared to primary PCI

Vincent Roule, Lin Schwob, Clément Briet, Adrien Lemaitre, Mathieu Bignon, Pierre Ardouin, Rémi Sabatier, Katrien Blanchart, Farzin Beygui

Safety and efficacy of short-term (1 to 3 months) dual antiplatelet therapy in patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trials

Babikir Kheiri, Timothy F. Simpson, Mohammed Osman, Harsh Golwala, Qais Radaideh, Kris Kumar, Hind Rahmouni, Punag Divanji, Joaquin E. Cigarroa, Firas Zahr

Predictors for layered coronary plaques: an optical coherence tomography study

Makoto Araki, Taishi Yonetsu, Michele Russo, Osamu Kurihara, Hyung Oh Kim, Hiroki Shinohara, Vikas Thondapu, Tsunenari Soeda, Yoshiyasu Minami, Takumi Higuma, Hang Lee, Tsunekazu Kakuta, Ik-Kyung Jang

Clinical significance of healed plaque detected by optical coherence tomography: a 2-year follow-up study

Osamu Kurihara, Michele Russo, Hyung Oh Kim, Makoto Araki, Hiroki Shinohara, Hang Lee, Masamichi Takano, Kyoichi Mizuno, Ik-Kyung Jang

Letter to the Editor

Risk Of Thrombosis In Elderly Immune Primary Trombocytopenic Patients Treated with Thrombopoietin Receptors Agonists

Roberto Castelli, Antonio Gidaro, Giorgio Lambertenghi Deliliers

Loop-mediated isothermal amplification (LAMP)-based method for detecting factor V Leiden and factor II G20210A common variants

Giovanni Luca Tiscia, Donatella Colaizzo, Patrizia Vergura, Giovanni Favuzzi, Elena Chinni, Charlotte Vandermeulen, Liselot Detemmerman, Elvira Grandone

Efficacy and safety of low dose rivaroxaban in patients with coronary heart disease: a systematic review and meta-analysis

Safi U. Khan, Muhammad Zia Khan, Zain Ul Abideen Asad, Shahul Valavoor, Muhammad Usman Khan, Muhammad Shahzeb Khan, Troy Krupica, Mohamad Alkhouli, Edo Kaluski

Effect of erroneous body-weight estimation on outcome of thrombolyzed stroke patients

Prakash R. Paliwal, Arvind K. Sharma, R. N. Komal Kumar, Lily Y. H. Wong, Bernard P. L. Chan, Hock Luen Teoh, Vijay K. Sharma

Thrombolysis in massive and submassive pulmonary embolism during pregnancy and the puerperium: a systematic review

David Rodriguez, Carlos Jerjes-Sanchez, Sugely Fonseca, Rebeca Garcia-Toto, Jhon Martinez-Alvarado, Jathniel Panneflek, Claudia Ortiz-Ledesma, Francisco Nevarez

Open Access

Assessment of the attitude, awareness and practice of periprocedural warfarin management among health care professional in Qatar. A cross sectional survey

Islam Eljilany, Ahmed El-Bardissy, Arwa Nemir, Abdel-Naser Elzouki, Ihab El Madhoun, Daoud Al-Badriyeh, Hazem Elewa

The Impact of platelet–fibrin clot strength on occurrence and clinical outcomes of peripheral artery disease in patients with significant coronary artery disease

Jae Seok Bae, Jong-Hwa Ahn, Jeong Yoon Jang, Sang Young Cho, Min Gyu Kang, Kye-Hwan Kim, Hyun Woong Park, Jin-Sin Koh, Yongwhi Park, Seok-Jae Hwang, Choong Hwan Kwak, Jin-Yong Hwang, Udaya S. Tantry, Paul A. Gurbel, Young-Hoon Jeong

Letter to the Editor

Rivaroxaban-induced hemorrhagic pericardial tamponade in end-stage renal disease

Nicole Rapista, Sauradeep Sarkar, Rahul Chaudhary

Acute phase treatment in central retinal artery occlusion: thrombolysis, hyperbaric oxygen therapy or both?

Daniel Ferreira, Carolina Soares, João Tavares-Ferreira, Tiago Fernandes, Rui Araújo, Pedro Castro

Low prevalence of JAK2 V617F mutation in patients with thrombosis and normal blood counts: a retrospective impact study

Michaël Levraut, Laurence Legros, Charles Drappier, Marie C. Béné, Viviane Queyrel, Sophie Raynaud, Nihal Martis

Albumin and bleed risk in rivaroxaban treated patients

E. Wojakowski, C. Cheruvil, A. Hassan, M. R. Holsen, L. Chen, M. Rossi, N. Wilcox, A. E. Woodruff

Letter to the Editor

Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019

Yoshihiko Ogawa, Toshihiko Nagata, Taisuke Akiyama, Koji Nishida, Junji Kumasawa, Michihiko Kohno, Hisakazu Kohata, Iwao Gohma

Zur Zeit gratis COVID-19 Letter to the Editor

Differentiating biochemical from clinical heparin resistance in COVID-19

Ton Lisman, Jecko Thachil

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.